Clinical Trial Update: Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sequential intensive chemotherapy followed by reduced-intensity conditioning for refractory and relapsed acute myeloid leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Acute Leukemia | Phase 2 | Status: COMPLETED